PharmiWeb.com - Global Pharma News & Resources
19-Apr-2020

Asklepios rejects demands by B. Braun and announces its intention to demand the convocation of an extraordinary general shareholders' meeting to remove and elect members of the Supervisory Board

RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): AGM/EGM/Offer
Asklepios rejects demands by B. Braun and announces its intention to demand the convocation of an extraordinary general shareholders' meeting to remove and elect members of the Supervisory Board

20-Apr-2020 / 00:34 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Asklepios rejects demands by B. Braun and announces its intention to demand the convocation of an extraordinary general shareholders' meeting to remove and elect members of the Supervisory Board

On 19 April 2020, the shareholder Asklepios Kliniken GmbH & Co. KGaA ("Asklepios") informed the Company, in response to the demand for convocation of a general shareholders' meeting submitted by the shareholder B. Braun Melsungen AG ("B. Braun") on 17 April 2020, that it rejects the demands of B. Braun to the increase of the majority requirement and make an advance dividend payment and that it intends to demand the convocation of an extraordinary general shareholders' meeting pursuant to Section 122 para. 1 of the German Stock Corporation Act (Aktiengesetz - AktG). Object of this general shareholders' meeting shall be the adoption of a resolution on the removal of the Supervisory Board members Dr. Annette Beller and Dr. Katrin Vernau. As reason for the desired removals, Asklepios states that Dr. Beller and Dr. Vernau would not act in accordance with the interests and benefit of the Company.

In addition, Asklepios announces its intention to propose that Dr. Julia Dannath-Schuh and Dr. Jan Liersch shall be elected as new Supervisory Board members instead of Dr. Beller and Dr. Vernau. Furthermore, Asklepios demands that its own demand to convene a general shareholders' meeting shall be dealt with before B. Braun's demand.

If received, the Management Board will also diligently examine a demand by Asklepios for convocation of a general shareholders' meeting and initiate the measures required by law.


20-Apr-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: RHÖN-KLINIKUM Aktiengesellschaft
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1024633

 
End of Announcement DGAP News Service

Editor Details

Last Updated: 19-Apr-2020